HC Wainwright Starts Aura Biosciences With Buy Rating, $21 Price Target
Aura Biosciences Price Target Announced at $21.00/Share by HC Wainwright & Co.
Aura Biosciences Analyst Ratings
H.C. Wainwright Initiates Aura Biosciences(AURA.US) With Buy Rating, Announces Target Price $21
Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Collplant Holdings (CLGN) and Zimmer Biomet Holdings (ZBH)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Generation Bio (GBIO), LAVA Therapeutics (LVTX) and Aura Biosciences Inc (AURA)
Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Iovance Biotherapeutics (IOVA) and Intellia Therapeutics (NTLA)
Scotiabank Remains a Buy on Aura Biosciences Inc (AURA)
Aura Biosciences Inc: A Buy Rating on Strong Pipeline and Financial Health
Analysts Conflicted on These Healthcare Names: Sanofi (OtherSNYNF), Molina Healthcare (MOH) and Aura Biosciences Inc (AURA)
Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Spectral AI (MDAI) and Pyxis Oncology (PYXS)
Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Altimmune (ALT)
BTIG Reaffirms Their Buy Rating on Aura Biosciences Inc (AURA)
BTIG Maintains Buy on Aura Biosciences, Lowers Price Target to $21
Aura Biosciences Analyst Ratings
Aura Biosciences Analyst Ratings
Positive Prospects for Aura Biosciences Inc. Despite Price Target Reduction: An Outperform Rating Maintained
Analysts' Top Healthcare Picks: Aura Biosciences Inc (AURA), Stereotaxis (STXS)
JMP Securities Sticks to Their Buy Rating for Aura Biosciences Inc (AURA)
Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Guardant Health (GH) and Day One Biopharmaceuticals (DAWN)